CTLA4 and cancer: Cancer cells mainly evade surveillance and killing of human immune system by interfering with immune checkpoints including PD-1, programmed cell death ligand-1 (PD-L1), and cytotoxic T lymphocyte-associated antigen-4 (CTLA-4) (Liu et al. 2023b).